Internal Medicine · Beverly Hills, CA
NPI
1346274834
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
8920 Wilshire Blvd Ste 635
Beverly Hills, CA, 90211
Phone (310) 652-3870
Medicare paid, 2024
$233K
8,795 services
Medicare patients, 2024
643
Average age 80
Drug cost, 2024
$546K
7,210 prescriptions
Company payments, 2025
$1,225
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Bamberger was code 99214 (office e&m - established), 745 times for 360 patients. In total Mark Bamberger billed 8,795 services in 79 codes, and Medicare paid $233K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 745 | 360 | $93.25 | $69K |
| 36415 Venipuncture Blood Collection | Office | 701 | 480 | $8.64 | $6,060 |
| 85025 Blood Count | Office | 654 | 465 | $7.61 | $4,977 |
| 80053 Clinical Chemistry | Office | 617 | 463 | $10.35 | $6,386 |
| 99215 Office E&M - Established | Office | 421 | 388 | $124.70 | $52K |
| 84443 Clinical Chemistry | Office | 404 | 373 | $16.46 | $6,650 |
| 84439 Clinical Chemistry | Office | 401 | 370 | $8.84 | $3,545 |
| 81003 Clinical Chemistry | Office | 387 | 347 | $2.20 | $851 |
| 80061 Clinical Chemistry | Office | 353 | 335 | $13.12 | $4,631 |
| 93000 Electrocardiogram | Office | 305 | 277 | $10.28 | $3,137 |
| 99213 Office E&M - Established | Office | 269 | 180 | $63.96 | $17K |
| 99232 Hospital E&M - Subsequent | Facility | 238 | 44 | $58.78 | $14K |
| 71046 X-ray - Chest | Office | 110 | 93 | $26.05 | $2,866 |
| 83036 Blood Count | Office | 106 | 73 | $9.52 | $1,009 |
| 82306 Clinical Chemistry | Office | 103 | 101 | $29.01 | $2,988 |
By year: 2022 $250K for 10,429 services; 2023 $260K for 12,043 services; 2024 $233K for 8,795 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 701 | 480 | $8.64 | $6,060 |
| 85025 Blood Count | 654 | 465 | $7.61 | $4,977 |
| 80053 Clinical Chemistry | 617 | 463 | $10.35 | $6,386 |
| 84443 Clinical Chemistry | 404 | 373 | $16.46 | $6,650 |
| 84439 Clinical Chemistry | 401 | 370 | $8.84 | $3,545 |
| 81003 Clinical Chemistry | 387 | 347 | $2.20 | $851 |
| 80061 Clinical Chemistry | 353 | 335 | $13.12 | $4,631 |
| 83036 Blood Count | 106 | 73 | $9.52 | $1,009 |
| 82306 Clinical Chemistry | 103 | 101 | $29.01 | $2,988 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 93 | 93 | $18.92 | $1,760 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark Bamberger prescribed most often to Medicare patients was Atorvastatin Calcium, with 498 prescriptions and refills. In total Mark Bamberger wrote 7,210 Medicare prescriptions that cost $546K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 498 | 1,325 | 132 | $4,920 |
| Levothyroxine Sodium Generic | 353 | 830 | 79 | $4,134 |
| Amlodipine Besylate Generic | 286 | 665 | 71 | $2,597 |
| Losartan Potassium Generic | 220 | 582 | 56 | $3,246 |
| Rosuvastatin Calcium Generic | 220 | 522 | 57 | $2,742 |
| Metoprolol Succinate Generic | 208 | 465 | 56 | $4,078 |
| Omeprazole Generic | 203 | 420 | 51 | $2,204 |
| Lisinopril Generic | 185 | 455 | 41 | $1,318 |
| Zolpidem Tartrate Generic | 175 | 222 | 51 | $1,145 |
| Tamsulosin Hcl Generic | 165 | 360 | 42 | $2,220 |
| Lorazepam Generic | 155 | 188 | 39 | $976 |
| Gabapentin Generic | 153 | 213 | 26 | $2,071 |
| Eliquis Apixaban | 132 | 179 | 25 | $103K |
| Furosemide Generic | 119 | 248 | 35 | $629 |
| Escitalopram Oxalate Generic | 119 | 268 | 33 | $1,873 |
Brand drugs: 888 claims; generic drugs: 6,305 claims; opioid claims: 84.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Bamberger $1,225 ($1,225 in general payments such as food, travel and fees) from 21 companies. The largest payer was Amgen Inc. with $198.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 9 | $198 |
| Novo Nordisk Inc NVO | 7 | $183 |
| Abbvie Inc. ABBV | 4 | $91.99 |
| Lundbeck LLC | 3 | $75.13 |
| Lilly USA, LLC LLY | 3 | $67.86 |
| GlaxoSmithKline, LLC. GSK | 3 | $66.59 |
| Merck Sharp & Dohme LLC MRK | 3 | $66.3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54.2 |
| Gilead Sciences, Inc. GILD | 2 | $52.56 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $42.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.